EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Safety and Efficacy of a Plug‐Based Vascular Closure Device After Percutaneous Microaxial Flow Pump in the Treatment of Complex and High‐Risk Indicated Patients

Jörg W Schröder iD, Norman Mangner iD, Felix J Woitek, Kai U Markus, Michael Lehrke, Felix Vogt, Marlo Verket, Alexandros Siskos, Moritz Biener, Benjamin Meder, Nicolas M Van Mieghem iD

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.31528 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Jörg W Schröder und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Angiology and Intensive Care, University Hospital RWTH Aachen, Aachen, Germany. Hauptthemen laut MEDLINE: Hemostatic Techniques, Vascular Closure Devices, Hemorrhage, Heart-Assist Devices. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by ABIOMED Europe GmbH, Germany..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Femoral large‐bore vascular access is an important and constantly increasing technique in interventional treatment. Temporary circulatory support in complex and high‐risk indicated patients (CHIP) presents a challenge in terms of postinterventional access site closure.

Aim

Monitoring the safety and efficacy of the MANTA system (Teleflex Inc.), a plug‐based vascular closure device (PbVCD) in patients receiving a percutaneous microaxial flow pump (mAFP).

Methods

A multicenter prospective all‐comers registry enrolled 73 consecutive patients scheduled for PbVCD after receiving mAFP for CHIP or cardiogenic shock. The primary endpoint was the occurrence of vascular complications at the mAFP access site until discharge according to the Valve Academic Research Consortium‐3 (VARC‐3) definition. Secondary endpoints included the rate of procedure‐ or device‐related bleedings, device‐failures, and the time to hemostasis. Operators rated on the use of the MANTA System and the similarity compared to ANGIOSEAL (Terumo Medical Corp.).

Results

Hemostasis was achieved in all 73 patients with no need for alternative treatment other than manual compression. The primary endpoint occurred in 7 (9.6%) patients with 1 (1.4%) patient suffering from a major vascular complication and 6 (8.2%) patients developing hematoma with type 2 bleeding (minor vascular complication). There was no vessel closure or thromboembolic event. In‐hospital survival was 100%.

Conclusions

The PbVCD system is a safe, efficient and easy‐to‐use vascular closure system for large‐bore vascular access in patients receiving a mAFP. Advantages and disadvantages of PbVCD and suture‐based vascular closure devices (SbVCD) systems should be individually adapted according to the patient's medical history and the anatomy of the vascular constellation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemostatic TechniquesVascular Closure DevicesHemorrhageHeart-Assist DevicesCatheterization, PeripheralFemoral ArteryHumansMaleFemaleProspective StudiesAgedTreatment OutcomeRisk FactorsTime FactorsRegistriesMiddle AgedPuncturesEquipment DesignAged, 80 and overRisk Assessment

Stichwörter der Autor:innen

CHIPMantableedingoutcomepercutaneous microaxial flow pumpplug‐based vascular closure device

Autor:innen und Institutionen

  • Department of Cardiology, Angiology and Intensive Care, University Hospital RWTH Aachen, Aachen, Germany.
  • Department of Internal Medicine and Cardiology, Heart Center Dresden, University Hospital, Technische Universität Dresden, Dresden, Germany.
  • VYSYO GmbH, Clinical Research, Eschweiler, Germany.
  • Department of Cardiology, Erasmus Medical Centre, Rotterdam, the Netherlands.
  • Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, Heidelberg, Germany.

ORCID-Profile: Jörg W Schröder, Norman Mangner, Nicolas M Van Mieghem

Förderung

  • This study was supported by ABIOMED Europe GmbH, Germany.

Zitieren

APA

Schröder, J. W., Mangner, N., Woitek, F. J., Markus, K. U., Lehrke, M., Vogt, F., Verket, M., Siskos, A., Biener, M., Meder, B., & Van Mieghem, N. M. (2025). Safety and Efficacy of a Plug‐Based Vascular Closure Device After Percutaneous Microaxial Flow Pump in the Treatment of Complex and High‐Risk Indicated Patients. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31528

Vancouver

Schröder JW, Mangner N, Woitek FJ, Markus KU, Lehrke M, Vogt F, et al. Safety and Efficacy of a Plug‐Based Vascular Closure Device After Percutaneous Microaxial Flow Pump in the Treatment of Complex and High‐Risk Indicated Patients. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31528

BibTeX
@article{Schrder2025,
  author = {Schröder, Jörg W and Mangner, Norman and Woitek, Felix J and Markus, Kai U and Lehrke, Michael and Vogt, Felix and Verket, Marlo and Siskos, Alexandros and Biener, Moritz and Meder, Benjamin and Van Mieghem, Nicolas M},
  title = {Safety and Efficacy of a Plug‐Based Vascular Closure Device After Percutaneous Microaxial Flow Pump in the Treatment of Complex and High‐Risk Indicated Patients},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.31528}
}
Kostenlos starten →